P155. Impact of Hospital Teaching Status On Outcomes In Type B Aortic Dissection: Analysis of 40,000 Patients
Presented During: POD Abstracts (Available for viewing in the exhibit hall for the duration of the meeting)
UPMC
Pittsburgh, PA
United States - Contact Me
Danial Ahmad is a Postdoctoral Associate in the division of cardiac surgery, department of cardiothoracic surgery at University of Pittsburgh. His current research interests are aortic diseases with a special focus on the thoracic aorta as well as structural heart disease.
Thursday, April 25, 2024: 5:38 PM - 7:00 PM
Sheraton Times Square
Room: Central Park
Description
Objectives:
In this study, we sought to assess the impact of a hospital's teaching status on survival and outcomes of patients presenting with type B aortic dissections (TBAD) across the United States. Additionally, we attempted to assess whether patient outcomes differed by TBAD management strategy.
Methods:
We reviewed The National Readmissions Database (NRD) to identify all TBAD between 2016 and 2020. Patients were stratified by hospital teaching status provided in the NRD. Subgroup analysis of open surgical repair (OSR) versus thoracic endovascular aortic repair (TEVAR) was undertaken. Mixed effects and logistic models were created for 30-day readmission and in-hospital mortality.
Results:
A total of 44,981 patients with a diagnosis of type B aortic dissection were included of which 12 % (5,421) received care at a metropolitan non-teaching (NT) hospital while 88% (39,470) were treated at a metropolitan teaching (T) hospital.
Younger patients (65 years (54-76) vs. 69 years (58-80), p<0.001) with TBAD presented at teaching hospitals and had longer durations of stay (6 days (3-12) vs. 5 days (2-9), p<0.01). The total adjusted charges were expectedly higher at teaching hospitals ($32,300 (12.3-70.2) vs. $16,900 (8.4-44.1), p<0.001). More females were treated at non-teaching hospitals compared to teaching hospitals (43.8% (2376) vs. 39.7% (15,653), p<0.001).
In-hospital mortality was higher at non-teaching hospitals (12.8% (694) vs 11.1% (4391), p<0.001). 30-day readmission rates were comparable between hospital types (NT: 23.2% (996) vs. T: 22% (6977), p=0.07). On both multivariable logistic regression for in-hospital death and multivariable mixed model for readmission, teaching status was not associated with the odds of the respective outcome.
On subgroup analysis, in-hospital death was comparable (NT: 3.8% (11) vs T: 5.5% (210), p=0.22) between hospital types in the TEVAR subgroup as were the 30-day readmission rates (NT: 27.3% (70) vs T: 22.8% (745), p=0.1). However, in the OSR subgroup, in-hospital death rate was lower at teaching hospitals (12.1% (275) vs. 17.8% (32), p=0.027). 30-day readmission rates were comparable in the OSR subgroup.
Conclusion:
Type B aortic dissections continue to be primarily managed by teaching hospitals, with superior in-hospital survival at teaching hospitals. Further, surgical management seems to yield better in-hospital survival at teaching hospitals while no such benefit is seen in TEVAR for TBAD at either type of institution.
Authors
Danial Ahmad (1), James Brown (1), Sarah Yousef (2), Derek Serna-Gallegos (3), Yisi Wang (1), David West (1), Pyongsoo Yoon (1), David Kaczorowski (4), Johannes Bonatti (5), Danny Chu (6), Francis Ferdinand (7), Julie Phillippi (8), Ibrahim Sultan (3)
Institutions
(1) UPMC, Pittsburgh, PA, (2) University of Pittsburgh, Pittsburgh, PA, (3) University of Pittsburgh Medical Center, Pittsburgh, PA, (4) University of Pittsburgh Medical Center, Venetia, PA, (5) UPMC Heart and Vascular Institute, Pittsburgh, PA, (6) Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, (7) UPMC, Erie, PA, (8) N/A, Pittsburgh, PA
In this study, we sought to assess the impact of a hospital's teaching status on survival and outcomes of patients presenting with type B aortic dissections (TBAD) across the United States. Additionally, we attempted to assess whether patient outcomes differed by TBAD management strategy.
Methods:
We reviewed The National Readmissions Database (NRD) to identify all TBAD between 2016 and 2020. Patients were stratified by hospital teaching status provided in the NRD. Subgroup analysis of open surgical repair (OSR) versus thoracic endovascular aortic repair (TEVAR) was undertaken. Mixed effects and logistic models were created for 30-day readmission and in-hospital mortality.
Results:
A total of 44,981 patients with a diagnosis of type B aortic dissection were included of which 12 % (5,421) received care at a metropolitan non-teaching (NT) hospital while 88% (39,470) were treated at a metropolitan teaching (T) hospital.
Younger patients (65 years (54-76) vs. 69 years (58-80), p<0.001) with TBAD presented at teaching hospitals and had longer durations of stay (6 days (3-12) vs. 5 days (2-9), p<0.01). The total adjusted charges were expectedly higher at teaching hospitals ($32,300 (12.3-70.2) vs. $16,900 (8.4-44.1), p<0.001). More females were treated at non-teaching hospitals compared to teaching hospitals (43.8% (2376) vs. 39.7% (15,653), p<0.001).
In-hospital mortality was higher at non-teaching hospitals (12.8% (694) vs 11.1% (4391), p<0.001). 30-day readmission rates were comparable between hospital types (NT: 23.2% (996) vs. T: 22% (6977), p=0.07). On both multivariable logistic regression for in-hospital death and multivariable mixed model for readmission, teaching status was not associated with the odds of the respective outcome.
On subgroup analysis, in-hospital death was comparable (NT: 3.8% (11) vs T: 5.5% (210), p=0.22) between hospital types in the TEVAR subgroup as were the 30-day readmission rates (NT: 27.3% (70) vs T: 22.8% (745), p=0.1). However, in the OSR subgroup, in-hospital death rate was lower at teaching hospitals (12.1% (275) vs. 17.8% (32), p=0.027). 30-day readmission rates were comparable in the OSR subgroup.
Conclusion:
Type B aortic dissections continue to be primarily managed by teaching hospitals, with superior in-hospital survival at teaching hospitals. Further, surgical management seems to yield better in-hospital survival at teaching hospitals while no such benefit is seen in TEVAR for TBAD at either type of institution.
Authors
Danial Ahmad (1), James Brown (1), Sarah Yousef (2), Derek Serna-Gallegos (3), Yisi Wang (1), David West (1), Pyongsoo Yoon (1), David Kaczorowski (4), Johannes Bonatti (5), Danny Chu (6), Francis Ferdinand (7), Julie Phillippi (8), Ibrahim Sultan (3)
Institutions
(1) UPMC, Pittsburgh, PA, (2) University of Pittsburgh, Pittsburgh, PA, (3) University of Pittsburgh Medical Center, Pittsburgh, PA, (4) University of Pittsburgh Medical Center, Venetia, PA, (5) UPMC Heart and Vascular Institute, Pittsburgh, PA, (6) Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, (7) UPMC, Erie, PA, (8) N/A, Pittsburgh, PA
Presentation Duration
PODS will be on display in the exhibit hall for the duration of the meeting during exhibit hall hours. PODS will also be available for viewing on the meeting website. There is no formal presentation associated with your POD, but we encourage you to visit the PODS area during breaks to connect with those viewing.